| Literature DB >> 25931764 |
Abstract
[Purpose] The sit-to-stand (STS) maneuver is a component of everyday mobility. The purpose of this review was to summarize the number of daily STSs performed by adults with or without pathology. [Methods] Four bibliographic databases were searched followed by a consultation with experts and a search by hand to locate articles reporting daily STSs. Information on measurement procedures, tested populations, and daily STSs was extracted. Methodological quality was rated.Entities:
Keywords: Chair-rise; Mobility; Sit-to-stand
Year: 2015 PMID: 25931764 PMCID: PMC4395748 DOI: 10.1589/jpts.27.939
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Summary of the 10 studies reporting accumulated daily sit-to-stands (STSs)
| Study | Measurement Procedure | Population | Daily STSs Mean±SD (95% CI) |
|---|---|---|---|
| Bohannon et al. | Talley counter used by participants for 7 days | United States Community-dwelling adults (51±21 years): n= 96 | 46±17 (43–49) Significantly more on weekdays than weekend days. |
| Dall and Kerr | ActivePAL attached to participants’ thighs for 3 or 7 days | Scotland Community-dwelling adults (40±9 years): n= 140 | 60±22 (57–64) Significantly more by indoor sedentary workers than outdoor active workers. Significantly more during working days than nonworking days. |
| Grant et al. | ActivePAL attached to participants’ thighs for up to 7 days | Scotland Community-dwelling older adults (74±5 years): n = 20 | 71±25 (59–83) |
| Scotland Day hospital attendees (75±8 years): n = 20 | 57±23 (46–68) | ||
| Scotland Hospital ward residents (81±6 years): n = 30 | 36±16 (30–42) | ||
| deBruin et al. | Custom device attached to participants’ sternum for 2 consecutive weekdays during 1 week and 1 of the same days the following week | Switzerland Residential care occupants (88±2 years): n = 11 | 60±23 (47–73) [week 1] 56±17 (45–67) [week 2] |
| Van den Berg-Emons et al. | Activity monitor attached to participants’ sternum and thighs for 2 consecutive weekdays | The Netherlands Individuals without congestive heart failure or mobility limitations (65±4 years): n = 5 | 54±19 (30–78) |
| The Netherlands Patients with congestive heart failure (64±5 years): n = 5 | 33±12 (18–48) | ||
| De Groot et al. | Activity monitor attached to participants’ sternum and thighs for 2 consecutive days | The Netherlands Healthy controls matched with patients scheduled for hip arthroplasty (59±12 years): n = 34 | 61±23 (53–69) |
| The Netherlands Healthy controls matched with patients scheduled for knee arthroplasty (60±11 years): n = 37 | 61±23 (54–68) | ||
| The Netherlands Patients with osteoarthritis scheduled for hip arthroplasty (60±13 years): n = 34 | 50±14 (45–55) | ||
| The Netherlands Patients with osteoarthritis scheduled for knee arthroplasty (61±10 years): n = 37 | 47±14 (42–52) | ||
| Egerton and Brauer | ActivePAL attached to participants’ thighs for 3 consecutive days | Australia Individuals living at home (71±4 years): n = 15 | 65±17 (56–74) |
| Australia Individuals living in aged care facilities (87±7 years): n = 16 | 47±27 (33–61) | ||
| Lord et al. | ActivePAL attached to participants’ thighs for 7 days | Australia Individuals living independently in community (79±5 years): n = 56 | 39±11 (36–42) |
| Maddocks and Wilcock | ActivePAL attached to participants’ thighs for 6 days (2 weekend) | England Patients with end-stage thoracic cancer (66±9 years): n = 84 | 45±17 (41–49) |
| Ryan et al. | ActivePAL attached to thigh for 7 days | Scotland Patients with low back pain (45±11 years): n = 38 | 59±16 (54–64) |
Assessment of methodological quality using a modification of the Hagströmer et al. Checklist for the 10 included studies
| Item | Bohannon et al. | Dall and Kerr | Grant et al. | De Bruin et al. | Van den Berg-Emons et al. | De Groot et al. | Egerton and Brauer | Lord et al. | Maddocks and Wilcock | Ryan et al. |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Objective clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 2. Activity clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 3. Participant character- istics clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| 5. Principal confounders clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| 6. Measurements clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 7. Data reduction clearly described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 8. Characteristics of participants with excluded data noted | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
| 9. Variability of activity data described | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 10. Confidence intervals reported | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 11. Representativeness of sample delineated | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 13. Research design comparable to other studies | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 14. Alteration in physical activity minimized | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 15. Research staff blinded | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 18. Compliance with protocol acceptable | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 19. Reproducibility of measure reported | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 10 | 11 | 12 | 8 | 6 | 8 | 9 | 9 |
1= yes, addressed; 0= not addressed or unable to determine